Is Venus Concept Inc (VERO) overvalued? · rev $64.8M
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
This page asks whether Venus Concept Inc (VERO) looks expensive on cached numbers — not a short thesis.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
VERO currently screens at market cap $578.2K. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VERO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VERO stock page for the full model, not this heading.
Not investment advice.